Piekos Brian

Track

Insider profile

Performance

Overall performance
1.5
Performance over holding periods
1.5
30 days 90 days 120 days
Average return -5% 8.2% 15.1%
Success rate 37% 68% 82%
Transactions
4 25% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Piekos Brian's trades of Kalvista Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
9.46
Quantity 7,655 +inf%
Value US$72,432
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-26 2026-05-22
S Sale
50,349 -25.5%
465.67
US$4,108,221 		50,349 -25.5% 465.67 US$4,108,221
2026-04-20 2026-04-17
S Sale
32,103 -11.9%
360.27
US$3,678,545 		32,103 -11.9% 360.27 US$3,678,545
2026-02-24 2026-02-23
S Sale
4,223 +31.3%
88.43
US$2,870,477 		4,223 +31.3% 88.43 US$2,870,477
2025-11-26 2025-11-24
S Sale
4,471 -29.8%
13.45
US$60,139 		4,471 -29.8% 13.45 US$60,139
2021-05-18 2021-05-14
B Purchase
7,655 +inf%
9.46
US$72,432 		7,655 +inf% 9.46 US$72,432